<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02546089</url>
  </required_header>
  <id_info>
    <org_study_id>UHL - 11334</org_study_id>
    <nct_id>NCT02546089</nct_id>
  </id_info>
  <brief_title>ABI v Dry Needling for Plantar Fasciitis</brief_title>
  <official_title>Investigating the Effects of Ultrasound Guided Autologous Blood Injection for Chronic Plantar Fasciitis Versus Ultrasound Guided Dry-needling Alone, a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals, Leicester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals, Leicester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate whether a procedure of ultrasound-guided autologous blood injections (ABI),&#xD;
      which includes a dry-needling component within the overall procedure, has any measureable&#xD;
      clinical benefit over ultrasound-guided dry needling alone in patients with chronic plantar&#xD;
      fasciitis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2014</start_date>
  <completion_date type="Actual">September 4, 2020</completion_date>
  <primary_completion_date type="Actual">September 4, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in pain - as assessed by 0-10 VAS scale</measure>
    <time_frame>3 &amp; 6 months - primary outcome set at 6 months for study, but using 3 month interim result as well</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in pain / improvement in function - as assessed by several PROMS (as below)</measure>
    <time_frame>3 &amp; 6 months</time_frame>
    <description>validated PROMs in use in this study include: FFI-r, MOXFQ, FAAM</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Plantar Fasciitis</condition>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>local anaesthetic - lidocaine 1%, dry needling, autologous blood injection,&#xD;
+ structured rehab programme</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>local anaesthetic - lidocaine 1%, dry needling,&#xD;
+ structured rehab programme</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Autologous Blood Injection</intervention_name>
    <description>ultrasound-guided autologous blood injection procedure</description>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Structured rehabilitation programme</intervention_name>
    <description>(this intervention is given to patients in both arms of the study) - a standardised structured rehabilitation programme of home exercises that the patient is instructed on how to start, and how to progress during the study period</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>dry needling injection</intervention_name>
    <description>(this intervention is given to patients in both arms of the study) - ultrasound-guided dry needling injection performed under ultrasound guidance</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients aged 18 or over who are being seen in the Department of Sports Medicine (all&#xD;
             of whom are age 16 or over) with chronic plantar fasciitis of at least 6 months&#xD;
             duration&#xD;
&#xD;
          2. Failure of previous conservative therapy - including physiotherapy, and podiatry input&#xD;
&#xD;
          3. Objective evidence of plantar fasciitis - either ultrasound or MRI investigations&#xD;
&#xD;
          4. No contraindications of injection therapy - anticoagulation, blood borne illness,&#xD;
             strong needle phobia â€¦&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with either partial or full-thickness tears of plantar fascia found on&#xD;
             investigations&#xD;
&#xD;
          2. Subjects who are unable to give valid consent for study entry based on normal&#xD;
             competency assessment&#xD;
&#xD;
          3. Subjects unable or unwilling to undergo the rehabilitation plan post-procedure&#xD;
&#xD;
          4. Subjects unable or unwilling to attend the follow-up appointments post-procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Wheeler</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHL NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals of Leicester NHS Trust</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 15, 2015</study_first_submitted>
  <study_first_submitted_qc>September 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2015</study_first_posted>
  <last_update_submitted>September 7, 2020</last_update_submitted>
  <last_update_submitted_qc>September 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

